Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Alderson

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell responseMichael N Starnbach, Wendy P Loomis, Pam Ovendale, et al.
The Journal of Infectious Diseases|November 1, 2019
Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate VaccinesMark R Alderson, F Marc LaForce, Ajoke Sobanjo-Ter Meulen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathwayDavid M Lewinsohn, Jeff E Grotzke, Amy S Heinzel, et al.
Human Vaccines & Immunotherapeutics|September 18, 2025
Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyondMark R Alderson, Katie Regan, Lionel Martellet, et al.
The Pediatric Infectious Disease Journal|January 3, 2020
A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in AdultsCheryl A Keech, Royce Morrison, Porter Anderson, et al.
Infection and Immunity|August 23, 2005
Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyproteinScott M Irwin, Angelo A Izzo, Steven W Dow, et al.
Vaccine|November 13, 2008
Identification of Mycobacterium tuberculosis vaccine candidates using human CD4+ T-cells expression cloningRhea N Coler, Davin C Dillon, Yasir A W Skeiky, et al.
Vaccine|May 27, 2005
Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41Yasir A W Skeiky, Mark R Alderson, Pamela J Ovendale, et al.
Infection and Immunity|March 23, 2006
Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitisLiana Tsenova, Ryhor Harbacheuski, Andre L Moreira, et al.
Journal of Pharmaceutical Sciences|November 20, 2012
Physical characterization and formulation development of a recombinant pneumolysoid protein-based pneumococcal vaccineLei Hu, Sangeeta B Joshi, Mangala Roshan Liyanage, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell responseMichael N Starnbach, Wendy P Loomis, Pam Ovendale, et al.
The Journal of Infectious Diseases|November 1, 2019
Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate VaccinesMark R Alderson, F Marc LaForce, Ajoke Sobanjo-Ter Meulen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathwayDavid M Lewinsohn, Jeff E Grotzke, Amy S Heinzel, et al.
Human Vaccines & Immunotherapeutics|September 18, 2025
Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyondMark R Alderson, Katie Regan, Lionel Martellet, et al.
The Pediatric Infectious Disease Journal|January 3, 2020
A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in AdultsCheryl A Keech, Royce Morrison, Porter Anderson, et al.
Infection and Immunity|August 23, 2005
Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyproteinScott M Irwin, Angelo A Izzo, Steven W Dow, et al.
Vaccine|November 13, 2008
Identification of Mycobacterium tuberculosis vaccine candidates using human CD4+ T-cells expression cloningRhea N Coler, Davin C Dillon, Yasir A W Skeiky, et al.
Vaccine|May 27, 2005
Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41Yasir A W Skeiky, Mark R Alderson, Pamela J Ovendale, et al.
Infection and Immunity|March 23, 2006
Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitisLiana Tsenova, Ryhor Harbacheuski, Andre L Moreira, et al.
Journal of Pharmaceutical Sciences|November 20, 2012
Physical characterization and formulation development of a recombinant pneumolysoid protein-based pneumococcal vaccineLei Hu, Sangeeta B Joshi, Mangala Roshan Liyanage, et al.
Pageof 4